Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Mydecine Innovations Group, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-1.87%
EBIT Growth (5y)
18.04%
EBIT to Interest (avg)
-6.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.46
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
-0.14
EV to EBIT
6.05
EV to EBITDA
6.05
EV to Capital Employed
-1.09
EV to Sales
NA
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
12What is working for the Company
PRE-TAX PROFIT(Q)
At CAD 0.07 MM has Grown at 128.65%
NET PROFIT(Q)
At CAD 0.07 MM has Grown at 128.65%
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Mydecine Innovations Group, Inc.
Pre-Tax Profit
At CAD 0.07 MM has Grown at 128.65%
over average net sales of the previous four periods of CAD -0.26 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CAD MM)
Net Profit
At CAD 0.07 MM has Grown at 128.65%
over average net sales of the previous four periods of CAD -0.26 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CAD MM)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






